Difficulty: Medium
Average Score: 81%
Practice
A 75-year-old man with a history of intermittent angina presents to his primary physician. The anginal attacks are becoming more frequent, and therapy is considered for this reason. His blood pressure is 160/95 mm Hg. Which of the following agents would be least likely to be administered as a first-line agent for this patient?
Correct answer
D
Rationale
In the case of a 75-year-old man with intermittent angina and elevated blood pressure, the least likely first-line agent would be Ranolazine (Option D).
Ranolazine is a relatively newer antianginal medication that is typically used as an add-on therapy in patients who have not responded adequately to other antianginal agents. It works by improving myocardial perfusion without affecting heart rate or blood pressure. Given the patient's elevated blood pressure, using traditional antianginal agents with known blood pressure-lowering effects would be more appropriate.
Diltiazem (Option A) and Nifedipine (Option B) are calcium channel blockers that not only help in angina but also have antihypertensive properties. Nitroglycerine (Option C) is a vasodilator commonly used to provide immediate relief during anginal attacks but is not typically used as a first-line agent for chronic angina management.
Educationally, this scenario highlights the importance of considering a patient's comorbidities and individualizing treatment based on their specific needs and medical history. Understanding the mechanism of action and side effect profiles of cardiovascular drugs is crucial in making informed decisions regarding pharmacological management.
Ranolazine is a relatively newer antianginal medication that is typically used as an add-on therapy in patients who have not responded adequately to other antianginal agents. It works by improving myocardial perfusion without affecting heart rate or blood pressure. Given the patient's elevated blood pressure, using traditional antianginal agents with known blood pressure-lowering effects would be more appropriate.
Diltiazem (Option A) and Nifedipine (Option B) are calcium channel blockers that not only help in angina but also have antihypertensive properties. Nitroglycerine (Option C) is a vasodilator commonly used to provide immediate relief during anginal attacks but is not typically used as a first-line agent for chronic angina management.
Educationally, this scenario highlights the importance of considering a patient's comorbidities and individualizing treatment based on their specific needs and medical history. Understanding the mechanism of action and side effect profiles of cardiovascular drugs is crucial in making informed decisions regarding pharmacological management.